In colorectal cancer cells, LINC00525 knockdown significantly reduced hypoxia-enhanced lactate production (Figure 3(d)) and glucose uptake (Figure 3(e)) (SW620, SW1116, and LoVo), similar to the above findings. Here, LINC00525 is linked to colorectal cancer.